Michelle Yanez - 05 May 2023 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
Director
Signature
/s/ Michelle Yanez
Issuer symbol
INTI
Transactions as of
05 May 2023
Net transactions value
$0
Form type
4
Filing time
17 May 2023, 19:09:26 UTC
Previous filing
22 Dec 2022
Next filing
02 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTI Common Stock Other $0 +796,271 +18089% $0.000000 800,673 05 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC.